Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AsiaMedicSGX:505 Current Ratio is 2.10 as of Dec. 2025, which is 6% above its 10-year median of 1.98. The stock has 4 warning signs investors should review. Among 212 Medical Diagnostics & Research companies, AsiaMedic ranks worse than 50.47% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. AsiaMedic's current ratio for the quarter that ended in Dec. 2025 was 2.10.
AsiaMedic has a current ratio of 2.10. It generally indicates good short-term financial strength.
The historical rank and industry rank for AsiaMedic's Current Ratio or its related term are showing as below:
SGX:505'
s Current Ratio Range Over the Past 10 Years
Min: 1.08 Med: 1.98 Max: 2.57
Current: 2.1
During the past 13 years, AsiaMedic's highest Current Ratio was 2.57. The lowest was 1.08. And the median was 1.98.
SGX:505's Current Ratio is ranked worse than 50.47% of 212
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.11
vs SGX:505: 2.10
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
AsiaMedic Current Ratio Related Terms
AsiaMedic Current Ratio Historical Data
* Premium members only.
The historical data trend for AsiaMedic's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SGX:505 vs TMO, DHR, IDXX: Current Ratio Comparison
For the Diagnostics & Research subindustry, AsiaMedic's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AsiaMedic Current Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, AsiaMedic's Current Ratio distribution charts can be found below:
* The bar in red indicates where AsiaMedic's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AsiaMedic (SGX:505) has a Current Ratio of 2.10 as of Dec. 2025. This is near median its historical median of 1.98. Over the past decade, AsiaMedic's Current Ratio has ranged from 1.08 to 2.57. According to the industry distribution chart, AsiaMedic ranks #107 out of 212 companies in the Medical Diagnostics & Research industry, placing it in the top 50.5%.
Is AsiaMedic's Current Ratio too high?
AsiaMedic's current Current Ratio of 2.10 is near median its 10-year median of 1.98. Over the past 10 years, this metric has ranged from a low of 1.08 to a high of 2.57. The Medical Diagnostics & Research industry median Current Ratio is 2.11. AsiaMedic's value of 2.10 is 0.5% below this industry median. Based on the distribution chart, AsiaMedic ranks #107 out of 212 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint.
How does AsiaMedic's Current Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, AsiaMedic ranks #107 out of 212 companies for Current Ratio. This places AsiaMedic in the lower half of its industry. The industry median Current Ratio is 2.11. AsiaMedic's value of 2.10 is 0.5% below this benchmark. Historically, AsiaMedic's own Current Ratio has ranged from 1.08 to 2.57 over the past decade. While the company's 10-year median is 1.98 vs. the industry median of 2.11, AsiaMedic has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Diagnostics & Research company?
The median Current Ratio among Medical Diagnostics & Research companies is 2.11, based on 212 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AsiaMedic's current Current Ratio of 2.10 is 0.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Diagnostics & Research industry, the median Current Ratio is 2.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AsiaMedic's current Current Ratio is 2.10, which is near median its own 10-year median of 1.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AsiaMedic stock overvalued right now?
Based on GuruFocus' analysis, AsiaMedic (SGX:505) is currently considered Modestly Overvalued. The stock's GF Value™ is S$0.02, compared to a current price of S$0.02 — trading 15% above its estimated fair value. The current Current Ratio is 2.10, which is near median its 10-year median of 1.98 and 0.5% below the Medical Diagnostics & Research industry median of 2.11. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For AsiaMedic (SGX:505), the current Current Ratio is 2.10 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
AsiaMedic Ltd is an investment holding company. The principal activities of the company include the provision of management services. It engaged in the business of operating medical clinics in Singapore. It generates revenue from health screening and medical wellness services, diagnostic imaging and radiology services, primary care services and sales of pharmaceutical products, and medical aesthetic services and related products, net of discounts.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:505 has been successfully added to your 
